Melanie Herman
Vice President, Investor Relations
Replay available
Ligand Pharmaceuticals Incorporated (LGND) Q1 2026 Earnings Call
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Todd Davis
Chief Executive Officer
Tavo Espinoza
Chief Financial Officer
Lauren Hay
Vice President, Portfolio Strategy and Investments
Michael Vigilante
Vice President, Investments and Business Development
Matthew Hewitt
Analyst, Craig Hallam Capital Group
Annabelle Samimi
Analyst, Stifel
Egal Notomovich
Analyst, Citigroup
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ligand Pharmaceuticals Incorporated.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.440 Hello, everyone. Thank you for joining us and welcome to Ligan first quarter 2026 earnings 00:00:05.440 -- 00:00:10.288 call. After today's prepared remarks, we will host a question and answer session. 00:00:10.288 -- 00:00:13.634 If you would like to ask a question, please press star one to raise your hand. 00:00:13.634 -- 00:00:16.539 To withdraw your question, press star one again. 00:00:16.539 -- 00:00:20.907 I will now hand the conference over to Melanie Herman. 00:00:20.907 -- 00:00:22.907 Please 00:00:23.671 -- 00:00:25.852 go ahead. 00:00:27.166 -- 00:00:31.714 Good morning, everyone, and welcome to Ligand's first quarter 2026 earnings call. 00:00:31.714 -- 00:00:36.684 With me on the call today are CEO Todd Davis, Chief Financial Officer Tavo Espinoza, 00:00:36.684 -- 00:00:41.512 Vice President of Portfolio Strategy and Investments Lauren Hay, and Vice President of 00:00:41.512 -- 00:00:45.059 Investments and Business Development Michael Vigilante. 00:00:45.059 -- 00:00:48.706 During the call today, we will review the financial results released earlier today and 00:00:48.706 -- 00:00:53.253 provide commentary on our partner portfolio, and business development activity, followed 00:00:53.253 -- 00:00:57.262 by a question and answer session. Before we get started, I would like to point out that 00:00:57.262 -- 00:01:01.814 we will be discussing non-GAAP results, which exclude certain items such as stock-based 00:01:01.814 -- 00:01:06.650 compensation, amortization of intangible assets, amortization or impairment of financial 00:01:06.650 -- 00:01:10.616 assets, and gains or losses from derivative assets, amongst others. 00:01:10.616 -- 00:01:14.221 I encourage you to review the reconciliation of these non-GAAP measures to t...